91ɫƵ

header-logo
GettyImages-650160957-hero

Froedtert & the 91ɫƵ Stroke Program

The Froedtert & 91ɫƵ Stroke Program was established in 1995 and was the first program of its kind in eastern Wisconsin. Within the multidisciplinary environment of the Froedtert & 91ɫƵ Neurosciences Research Center, the Stroke Program offers a comprehensive approach to care, and has received a Comprehensive Stroke Center designation by the Joint Commission as well as several awards for the excellent care provided.

Clinical services of the Stroke Program center around F.A.S.T., the Froedtert & 91ɫƵ Acute Stroke Team. This emergency code stroke team responds to any acute stroke call 24 hours a day, 7 days a week. F.A.S.T. provides immediate and experienced neurological expertise to carefully assess the needs and therapeutic options for a stroke patient. Effective and safe treatment of stroke requires patients, and healthcare providers, to "Think FAST" to access immediate expert emergency medical attention. As growing public awareness prompts patients to "Call 911-Stroke is a medical emergency!", F.A.S.T. guarantees an appropriate hospital response unique in the area.

Froedtert & 91ɫƵ provide the latest therapeutics in stroke care. Intravenous thrombolytic therapy has been successfully used here since 1996, administered only under the direction of our vascular neurologists. Endovascular Therapy is completed by a group of highly skilled endovascular surgeons. Froedtert & 91ɫƵ have adopted a collaborative approach where patients are reviewed in multidisciplinary conferences. The latest technology and treatments are applied to aneurysm coiling, carotid stents, vascular malformations, and other complex neurovascular cases. Cutting edge technology is used at Froedtert hospital, with the faculty actively involved in various national clinical trials and remain leaders in clinical care. The program has grown over the years to become a regional resource for both urgent inpatient referral and elective outpatient care of challenging neurovascular patients.